McNamara Peter
Chief Scientific Officer
- Shares
- 536
- Price
- $23.04
- Value
- $12,349
TECX
1 seller account for the net balance. There is no cluster of three distinct buyers within 30 days. We found 3 CEO/CFO purchases over 12 months.
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
−$15,425
0 buyers · 1 sellers
12-month purchases
$235,160
2 distinct insiders
12-month sales
$651,007
2 distinct insiders
Highlighted alerts
3
11 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
3 executive purchases found
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
TECX overview: breakout setup, X sentiment and insiders in one page →
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
These shares are held by the Reicin-Boiarsky Family Trust (the "Trust"). The Reporting Person's spouse is a co-trustee of the Trust. Accordingly, the Reporting Person may be deemed to have shared voting and dispositive power over the securities held by the Trust. The Reporting Person disclaims beneficial ownership of the shares held by the Trust except to the extent of her pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. The shares subject to the option vested as follows: (i) 4,079 shares on June 30, 2024; (ii) 4,078 shares on July 31, 2024, (iii) 4,078 shares on August 31, 2024, (iv) 4,079 shares on September 30, 2024, (v) 4,078 shares on October 31, 2024, (vi) 1,297 shares on November 30, 2024, (vii) 4,078 shares on January 31, 2025, (viii) 4,078 shares on February 28, 2025 and (iv) 4,078 shares on March 31, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. Received in exchange for a stock option to acquire 63,478 shares of common stock pursuant to that certain merger, as more fully described on the Reporting Person's Form 4 filed with the Securities and Exchange Commission on June 24, 2024. https://www.sec.gov/Archives/edgar/data/1681087/000141588924017952/xslF345X05/form4-06242024_080648.xml
Voluntary purchases and sales; administrative noise stays hidden.
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
Ruddy Marcella K.
Chief Medical Officer
Ruddy Marcella K.
Chief Medical Officer
Ruddy Marcella K.
Chief Medical Officer
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
McNamara Peter
Chief Scientific Officer
REICIN ALISE
Chief Executive Officer
REICIN ALISE
Chief Executive Officer
Lochner Daniel
Chief Financial Officer
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | McNamara Peter Chief Scientific Officer | Sale | 536 | $23.04 | $12,349 | |
| Aug 25, 2026 | McNamara Peter Chief Scientific Officer | Sale | 43 | $36.52 | $1,570 | |
| Aug 12, 2026 | McNamara Peter Chief Scientific Officer | Sale | 43 | $35.00 | $1,505 | |
| Jun 30, 2026 | McNamara Peter Chief Scientific Officer | Sale | 172 | $35.00 | $6,020 | |
| May 04, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 1,065 | $30.00 | $31,950 | |
| Apr 01, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 1,000 | $31.05 | $31,050 | |
| Mar 06, 2026 | Ruddy Marcella K. Chief Medical Officer | Sale | 10,000 | $30.00 | $300,000 | |
| Mar 06, 2026 | McNamara Peter Chief Scientific Officer | Sale | 215 | $35.00 | $7,525 | |
| Mar 06, 2026 | McNamara Peter Chief Scientific Officer | Sale | 6,047 | $30.00 | $181,410 | |
| Mar 04, 2026 | McNamara Peter Chief Scientific Officer | Sale | 1,650 | $25.00 | $41,250 | |
| Mar 03, 2026 | McNamara Peter Chief Scientific Officer | Sale | 1,649 | $22.06 | $36,377 | |
| Feb 11, 2026 | REICIN ALISE Chief Executive Officer | Purchase | 2,500 | $21.10 | $52,750 | |
| Feb 11, 2026 | REICIN ALISE Chief Executive Officer | Purchase | 2,500 | $21.10 | $52,750 | |
| Feb 10, 2026 | Lochner Daniel Chief Financial Officer | Purchase | 6,000 | $21.61 | $129,660 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.